NEW PROSTATE CANCER INFOLINK: Research into a fused gene present in prostate cancer patients shows it is not a helpful marker in predicting the effectiveness of hormone therapy. READ MORE>

We will have to hope that presence of the TMPRSS2-ERG fusion gene can be used to predict something else about prostate cancer — otherwise what we will have is a very common “marker” that has no apparent clinical value.